CN102805841B - Medicament for treating adverse reaction caused by anesthetics - Google Patents

Medicament for treating adverse reaction caused by anesthetics Download PDF

Info

Publication number
CN102805841B
CN102805841B CN2012103008862A CN201210300886A CN102805841B CN 102805841 B CN102805841 B CN 102805841B CN 2012103008862 A CN2012103008862 A CN 2012103008862A CN 201210300886 A CN201210300886 A CN 201210300886A CN 102805841 B CN102805841 B CN 102805841B
Authority
CN
China
Prior art keywords
medicament
anesthetics
root
adverse reaction
reaction caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2012103008862A
Other languages
Chinese (zh)
Other versions
CN102805841A (en
Inventor
张磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012103008862A priority Critical patent/CN102805841B/en
Publication of CN102805841A publication Critical patent/CN102805841A/en
Application granted granted Critical
Publication of CN102805841B publication Critical patent/CN102805841B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a medicament for treating an adverse reaction caused by anesthetics. The medicament is prepared from common burreed rhizome, chaulmoogratree seed, glossy privet fruit, turmeric root-tuber, meadowrue root and rhizome, common scouring rush herb, blackend swallowwort root, spina date seed, manchurian wildginger, pyrrosia leaf, trogopterus dung, yunnan manyleaf paris rhizome, pinellia tuber, acanthopanax root and frankincense. The medicament is reasonable in components and obvious in curative effect, and can be used for treating the adverse reaction caused by the anesthetics effectively.

Description

A kind of medicament for the treatment of the anesthetics untoward reaction
Technical field
The present invention relates to the clinical anesthesia field, particularly, the present invention relates to a kind of medicament for the treatment of the anesthetics untoward reaction.
Background technology
For the capable cesarean anemia of pregnant woman of needs, often take local infiltration anesthesia+ketamine, but the reason such as operating difficulties in the bad and art of anaesthetic effect sometimes needs to extend operating time, increase anesthetics dosage, thereby cause the generation of anaesthetic side reaction in various degree.Common are paraesthesia, dysphoria, muscular tremor, convulsions, respiration inhibition etc.Clinical treatment is main mainly with Western medicine at present, but the symptom for the treatment of own is untoward reaction, while adopting western medicine, even can increase the weight of this untoward reaction.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of the anesthetics untoward reaction.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of the anesthetics untoward reaction, it is characterized in that, it is the medicament of being made according to weight proportion by following ingredients:
Figure BSA00000767099100011
Preferably, the medicament for the treatment of anesthetics of the present invention untoward reaction is the medicament of being made according to weight proportion by following ingredients:
Figure BSA00000767099100012
The medicament for the treatment of anesthetics of the present invention untoward reaction can be made various dosage forms according to technological means well-known to those skilled in the art, for example tablet, dispersible tablet, buccal tablet, fast disintegrating tablet, capsule, hard capsule or decoction.
The medicine component for the treatment of anesthetics of the present invention untoward reaction is reasonable, evident in efficacy, can effectively treat the anesthetics untoward reaction.
The specific embodiment
The following examples will be further described the present invention, but not thereby limiting the invention.
The preparation of embodiment 1 decoction of the present invention
Get Rhizoma Sparganii 500 grams, Semen Hydnocarpi 300 grams, Fructus Ligustri Lucidi 2000 grams, Radix Curcumae 500 grams, Radix et Rhizoma Thalictri 2000 grams, Herba Equiseti Hiemalis's 500 grams, Radix Cynanchi Atrati 300 grams, Semen Ziziphi Spinosae 1000 grams, Herba Asari 1500 grams, Folium Pyrrosiae 300 grams, Oletum Trogopterori 1500 grams, Rhizoma Paridis 300 grams, the Rhizoma Pinelliae 1000 grams, Radix Et Caulis Acanthopanacis Senticosi 300 grams, Olibanum 300 grams, add 20 liters, water, under the condition refluxed, heating is 3 hours, filter, filtrate is cooled to room temperature, obtains.
Experimental example
Observe case 50 examples, be the cesarean postoperative patient, anesthesia method adopts local infiltration anesthesia+ketamine, age 23-38 year.Observe patient's untoward reaction.Wherein paraesthesia, dysphoria, muscular tremor appear in 20 examples; Paraesthesia, convulsions, respiration inhibition appear in 30 examples.The patient starts medication when adverse effect occurring.200 milliliters of the decoctions of the present invention that medication is preparation in oral embodiment 1.The decoction of the present invention of preparation in oral embodiment 1, the situation that continues to observe the patient.
1. in art, postoperative patient mind is fully clear-headed, to the sensation after medication, can talk clearly the patient possesses following situations:, be ready to coordinate.2. to the patient, oral Chinese medicine purpose, method and points for attention and safety etc. are described, to obtain patient's cooperation.
After treatment 5 minutes, there is 25 routine patients' untoward reaction symptom to disappear fully, feel very good, routine examination blood pressure, pulse are all normal; After 10 minutes, there is again 20 routine patients' untoward reaction symptom to disappear fully, feel very good, routine examination blood pressure, pulse are all normal; After 15 minutes, the untoward reaction symptom that remains 5 routine patients disappears fully, feels very good, and routine examination blood pressure, pulse are all normal.

Claims (2)

1. a medicament for the treatment of the anesthetics untoward reaction, is characterized in that, it is the medicament of being made according to weight proportion by following ingredients:
Figure FSB0000111263110000011
2. the medicament for the treatment of anesthetics according to claim 1 untoward reaction, is characterized in that, it is the medicament of being made according to weight proportion by following ingredients:
Figure FSB0000111263110000012
CN2012103008862A 2012-08-23 2012-08-23 Medicament for treating adverse reaction caused by anesthetics Expired - Fee Related CN102805841B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012103008862A CN102805841B (en) 2012-08-23 2012-08-23 Medicament for treating adverse reaction caused by anesthetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012103008862A CN102805841B (en) 2012-08-23 2012-08-23 Medicament for treating adverse reaction caused by anesthetics

Publications (2)

Publication Number Publication Date
CN102805841A CN102805841A (en) 2012-12-05
CN102805841B true CN102805841B (en) 2013-12-04

Family

ID=47229825

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012103008862A Expired - Fee Related CN102805841B (en) 2012-08-23 2012-08-23 Medicament for treating adverse reaction caused by anesthetics

Country Status (1)

Country Link
CN (1) CN102805841B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103920005B (en) * 2014-04-28 2016-06-22 李学新 Medicine is intervened before a kind of neurosurgery general anesthesia patients
CN104189849A (en) * 2014-09-22 2014-12-10 宋吉玲 Traditional Chinese medicine composition for preventing adverse reaction after anesthesia and preparation method of traditional Chinese medicine composition
CN104547447A (en) * 2015-01-27 2015-04-29 张华朋 Traditional Chinese medicine liquid for treating adverse reaction of anesthetic and preparation method of traditional Chinese medicine liquid
CN104771624A (en) * 2015-03-24 2015-07-15 高英 Traditional Chinese medicinal composition for treating anesthetic adverse reaction
CN105125982A (en) * 2015-10-13 2015-12-09 张瑞英 Anesthetic for treating anorectal diseases
CN105250934A (en) * 2015-11-11 2016-01-20 侯明时 High-performance anaesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101371855A (en) * 2007-08-22 2009-02-25 詹承镇 Safety anaesthetic
CN101919891A (en) * 2009-06-15 2010-12-22 詹承镇 Scheme II safe anesthetic
CN102344408B (en) * 2011-07-27 2013-06-05 中国人民解放军第四军医大学 Double-effect anesthetic

Also Published As

Publication number Publication date
CN102805841A (en) 2012-12-05

Similar Documents

Publication Publication Date Title
CN102805841B (en) Medicament for treating adverse reaction caused by anesthetics
CN103919940A (en) Chinese medicinal composition for treating hemorrhoid
CN102028842B (en) Medicament for treating dysmenorrhea and preparation method thereof
CN103301400A (en) Traditional Chinese medicinal composition for treating chronic atrophic gastritis and preparation method of traditional Chinese medicinal composition
CN102274252B (en) Stauntonvine external applied preparation for treating rheumatoid diseases and preparation method thereof
CN101804189B (en) Drug for treating primary dysmenorrhea
CN102389508B (en) Traditional Chinese medicine for treating infertility
CN103550643A (en) Traditional Chinese medicine for treating tuberculosis
CN103585591A (en) Traditional Chinese medicine for treating gallstones
CN102657819B (en) Drug combination for treating dysthymic disorder
CN102552671B (en) Medicament for curing neurasthenia
CN101745048B (en) Medicine for treating type II diabetes and resisting aging
CN103720981A (en) Traditional Chinese medicine for treating dysentery
CN103611129A (en) Traditional Chinese medicine for treating neuropathic headache
CN103446545B (en) Traditional Chinese medicine composition for treating chronic atrophic gastritis and preparation method thereof
CN102283993B (en) Traditional Chinese medicine composition for treating systemic lupus erythematosus
CN102512555B (en) Medicinal composition for treating epigastric pain
CN102526385B (en) Medicament for treating climacteric syndrome
CN104758884A (en) Traditional Chinese medicine composition for treating asthma
CN103405660A (en) Compound medicine for treating headache
CN103272059A (en) Traditional Chinese medicinal decoction for treating pyretic toothache
CN101843718B (en) Chinese medicament for treating lupus erythematosus
CN102813875B (en) Traditional Chinese medicine composition for treating lupus erythematosus as well as application thereof
CN102526373B (en) Medicinal composition for treating infantile anorexia
CN103182037A (en) Traditional Chinese medicine for treating rhinitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131204

Termination date: 20150823

EXPY Termination of patent right or utility model